Heartbeam Inc (BEAT) - Total Liabilities
Based on the latest financial reports, Heartbeam Inc (BEAT) has total liabilities worth $2.46 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Heartbeam Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Heartbeam Inc - Total Liabilities Trend (2003–2025)
This chart illustrates how Heartbeam Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Heartbeam Inc asset portfolio.
Heartbeam Inc Competitors by Total Liabilities
The table below lists competitors of Heartbeam Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Point Mobile Co. Ltd
KQ:318020
|
Korea | ₩43.69 Billion |
|
Welsbach Technology Metals Acquisition Corp
NASDAQ:WTMA
|
USA | $12.63 Million |
|
UTStarcom Holdings Corp
NASDAQ:UTSI
|
USA | $16.82 Million |
|
Duckshin Housing Co. Ltd
KQ:090410
|
Korea | ₩94.73 Billion |
|
Inception Growth Acquisition Ltd
NASDAQ:IGTA
|
USA | $7.15 Million |
|
BRIDGETEC Corp
KQ:064480
|
Korea | ₩11.50 Billion |
|
Litium AB (publ)
ST:LITI
|
Sweden | Skr20.89 Million |
|
Alpine Summit Energy Partners Inc
NASDAQ:ALPS
|
USA | $12.97 Million |
Liability Composition Analysis (2003–2025)
This chart breaks down Heartbeam Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See BEAT net asset quality score to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.66 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.30 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Heartbeam Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Heartbeam Inc (2003–2025)
The table below shows the annual total liabilities of Heartbeam Inc from 2003 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $3.24 Million | +99.75% |
| 2024-12-31 | $1.62 Million | +35.85% |
| 2023-12-31 | $1.19 Million | -28.29% |
| 2022-12-31 | $1.67 Million | +183.16% |
| 2021-12-31 | $588.00K | -87.84% |
| 2020-12-31 | $4.84 Million | +29.51% |
| 2019-12-31 | $3.73 Million | -98.65% |
| 2018-12-31 | $276.32 Million | +0.53% |
| 2017-12-31 | $274.86 Million | +357.56% |
| 2016-12-31 | $60.07 Million | +24.58% |
| 2015-12-31 | $48.22 Million | -21.09% |
| 2014-12-31 | $61.10 Million | +194.94% |
| 2013-12-31 | $20.72 Million | +3.52% |
| 2012-12-31 | $20.01 Million | +17.87% |
| 2011-12-31 | $16.98 Million | -21.99% |
| 2010-12-31 | $21.76 Million | +14.73% |
| 2009-12-31 | $18.97 Million | +21.16% |
| 2008-12-31 | $15.66 Million | -87.95% |
| 2007-12-31 | $129.90 Million | +250.84% |
| 2006-12-31 | $37.03 Million | +44.83% |
| 2004-12-31 | $25.57 Million | +80.66% |
| 2003-12-31 | $14.15 Million | -- |
About Heartbeam Inc
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection … Read more